Arsenic and cardiac failure Patient Reports February 12, 2012

Arsenic Side Effects Report #5926589-9
Arsenic side effect was reported by a Health Professional from ITALY on Oct 01, 2008. Male patient, 75 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, cardiac failure, electrocardiogram repolarisation abnormality, hypoxia, pco2 decreased, platelet count decreased, sinus tachycardia. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN HYDROCHLORIDE, LENOGASTRIM, ASCORBIC ACID, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5853385-3
Arsenic side effect was reported by a Physician from ITALY on Jan 23, 2008. Male patient, 74 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, cardiac failure, dyspnoea, pco2 decreased, platelet count decreased, po2 decreased. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN, LENOGASTRIM. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5919004-2
Arsenic side effect was reported by a Physician from ITALY on Oct 01, 2008. Male patient, 74 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, cardiac failure, dyspnoea, electrocardiogram repolarisation abnormality, hypoxia, sinus tachycardia. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN, LENOGRASTIM, ASCORBIC ACID, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5994520-6
Arsenic side effect was reported by a Physician from ITALY on Dec 04, 2008. Male patient, 74 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, cardiac failure, dyspnoea, pco2 decreased, platelet count decreased, po2 decreased, sinus tachycardia. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN, LENOGRASTIM, ASCORBIC ACID, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.


Arsenic Side Effects Report #4903386-4
Arsenic side effect was reported by a Physician from JAPAN on Jan 20, 2006. Male patient, 24 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac failure, convulsion, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, extrasystoles, palpitations, renal impairment, ventricular tachycardia. Arsenic dosage: 9.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ARSENIC TRIOXIDE, TRETINOIN, FLUCONAZOLE, SULFAMETHOXAZOLE, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #4978889-7
Arsenic side effect was reported by a Physician from JAPAN on Apr 04, 2006. Female patient, 24 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac failure, convulsion, electrocardiogram qt corrected interval prolonged, electrocardiogram qt prolonged, extrasystoles, palpitations, renal impairment. Arsenic dosage: 9.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with ARSENIC TRIOXIDE, TRETINOIN, FLUCONAZOLE, SULFAMETHOXAZOLE, FUROSEMIDE. Patient was hospitalized. Patient recovered.